Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Single Cell Bioinformatics Software and Services Market: By Component, By Application, Microbiology Others), By End User and Geography
1. Executive Summary |
2. Global Single Cell Bioinformatics Software and Services Market Introduction |
2.1. Global Single Cell Bioinformatics Software and Services Market – Taxonomy |
2.2. Global Single Cell Bioinformatics Software and Services Market –Definitions |
2.2.1. Component |
2.2.2. Application |
2.2.3. End User |
3. Global Single Cell Bioinformatics Software and Services Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Single Cell Bioinformatics Software and Services Market Dynamic Factors - Impact Analysis |
3.6. Global Single Cell Bioinformatics Software and Services Market – Competition Landscape |
3.7. Epidemiology |
4. Global Single Cell Bioinformatics Software and Services Market Analysis,2017-2021 and Forecast, 2022-2028 |
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Single Cell Bioinformatics Software and Services Market, By Component, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
5.1. Bioinformatics Software |
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Bioinformatics Services |
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Single Cell Bioinformatics Software and Services Market Forecast, By Application, 2017-2021 and Forecast, 2021 – 2027 (Revenue, US$ Mn) |
6.1. Oncology |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Immunology |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Neurology |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Non-invasive Prenatal Diagnosis (NIPD) |
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Microbiology |
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Others |
6.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
7. Global Single Cell Bioinformatics Software and Services Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
7.1. Biopharmaceutical and Biotechnology Companies |
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Research and Academic Institutes |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8. Global Single Cell Bioinformatics Software and Services Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
8.1. North America |
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By Component, Application, End User and Region, 2022-2028 |
9. North America Single Cell Bioinformatics Software and Services MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
9.1. By Component Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Bioinformatics Software |
9.1.2. Bioinformatics Services |
9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Oncology |
9.2.2. Immunology |
9.2.3. Neurology |
9.2.4. Non-invasive Prenatal Diagnosis (NIPD) |
9.2.5. Microbiology |
9.2.6. Others |
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Biopharmaceutical and Biotechnology Companies |
9.3.2. Research and Academic Institutes |
9.3.3. Others |
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. USA |
9.4.2. Canada |
9.5. North America Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By Component, Application, End User, and Country, 2022-2028 |
9.6. North America Single Cell Bioinformatics Software and Services Market Dynamics – Trends |
10. Europe Single Cell Bioinformatics Software and Services Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
10.1. By Component Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Bioinformatics Software |
10.1.2. Bioinformatics Services |
10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Oncology |
10.2.2. Immunology |
10.2.3. Neurology |
10.2.4. Non-invasive Prenatal Diagnosis (NIPD) |
10.2.5. Microbiology |
10.2.6. Others |
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Biopharmaceutical and Biotechnology Companies |
10.3.2. Research and Academic Institutes |
10.3.3. Others |
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Rest of Europe |
10.5. Europe Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By Component, Application, End User, and Country, 2022-2028 |
10.6. Europe Single Cell Bioinformatics Software and Services Market Dynamics – Trends |
11. Asia-Pacific Single Cell Bioinformatics Software and Services Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
11.1. By Component Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Bioinformatics Software |
11.1.2. Bioinformatics Services |
11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Oncology |
11.2.2. Immunology |
11.2.3. Neurology |
11.2.4. Non-invasive Prenatal Diagnosis (NIPD) |
11.2.5. Microbiology |
11.2.6. Others |
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Biopharmaceutical and Biotechnology Companies |
11.3.2. Research and Academic Institutes |
11.3.3. Others |
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Japan |
11.4.2. China |
11.4.3. India |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By Component, Application, End User, and Country, 2022-2028 |
11.6. Asia-Pacific Single Cell Bioinformatics Software and Services Market Dynamics – Trends |
12. Latin America Single Cell Bioinformatics Software and Services Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
12.1. By Component Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Bioinformatics Software |
12.1.2. Bioinformatics Services |
12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Oncology |
12.2.2. Immunology |
12.2.3. Neurology |
12.2.4. Non-invasive Prenatal Diagnosis (NIPD) |
12.2.5. Microbiology |
12.2.6. Others |
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Biopharmaceutical and Biotechnology Companies |
12.3.2. Research and Academic Institutes |
12.3.3. Others |
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Argentina |
12.4.4. Rest of Latin America |
12.5. Latin America Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By Component, Application, End User, and Country, 2022-2028 |
12.6. Latin America Single Cell Bioinformatics Software and Services Market Dynamics – Trends |
13. Middle East and Africa Single Cell Bioinformatics Software and Services Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
13.1. By Component Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Bioinformatics Software |
13.1.2. Bioinformatics Services |
13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Oncology |
13.2.2. Immunology |
13.2.3. Neurology |
13.2.4. Non-invasive Prenatal Diagnosis (NIPD) |
13.2.5. Microbiology |
13.2.6. Others |
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Biopharmaceutical and Biotechnology Companies |
13.3.2. Research and Academic Institutes |
13.3.3. Others |
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. Israel |
13.4.3. South Africa |
13.4.4. Rest of MEA |
13.5. MEA Single Cell Bioinformatics Software and Services Market - Opportunity Analysis Index, By Component, Application, End User, and Country, 2022-2028 |
13.6. MEA Single Cell Bioinformatics Software and Services Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Fluidigm Corporation |
14.2.2. QIAGEN |
14.2.3. Mission Bio |
14.2.4. Illumina, Inc. |
14.2.5. Takara Inc. |
14.2.6. BD |
14.2.7. PacBio |
14.2.8. BioBam |
14.2.9. IsoPlexis |
15. Research Methodology |
16. Key Assumptions and Acronyms |
Download Free Sample Report
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Market Players